BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Drug Development

  Results from AbbVie’s Study Of VIEKIRA PAK (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) In Chronic Hepatitis C Patients With HIV-1 Co-Infection (TURQUOISE-I) Published Online In JAMA; Sub-Analyses To Be Presented At The Annual Conferen

  February 23, 2015

   · 

  12 min read
• Deals

  Tekni-Plex’s Plan To Acquire Gallazzi’s Italian Pharma Blister Film, Adhesive Tape Substrate Film Businesses Has Been Approved

  February 23, 2015

   · 

  2 min read
• Business

  Nakashima And Teijin Limited To Establish Joint Venture For Global Expansion Of Japanese-Made Medical Device Business

  February 23, 2015

   · 

  4 min read
• Pharm Country

  FDA Grants Seven Years’ Market Exclusivity To Eagle Pharmaceuticals’ Ryanodex For The Treatment Of Malignant Hyperthermia

  February 23, 2015

   · 

  3 min read
• Otic Pharma Announces Encouraging Feedback From A Pre-IND Meeting With The FDA

  February 23, 2015

   · 

  3 min read
• Opsona Therapeutics Ltd. Patent Issued In USA Covering An Antibody Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof

  February 23, 2015

   · 

  3 min read
• Business

  Mitobridge Secures Key Intellectual Property From The Salk Institute for Biological Studies

  February 23, 2015

   · 

  4 min read
• Drug Development

  NovoCure Ltd. Enrolls The First Patient In Its Phase II STELLAR Trial Of Tumor Treating Fields Together With Pemetrexed And Cisplatin Or Carboplatin For The Treatment Of Malignant Mesothelioma

  February 23, 2015

   · 

  3 min read
• Deals

  Marathon Pharmaceuticals, LLC Prepares For Launch Of New Rare Disease Treatments By Selling Non-Strategic Products To Valeant Including Isuprel And Nitropress

  February 23, 2015

   · 

  2 min read
• Drug Development

  Addex Therapeutics Initiates Dipraglurant Receptor Occupancy Clinical Study In Collaboration With Johns Hopkins University With Funding From The Michael J. Fox Foundation

  February 23, 2015

   · 

  6 min read